Fixed-dose combination antihypertensive medications

dc.contributor.author	Benjamin, Ivor J.
dc.contributor.author	Schutte, Aletta E.
dc.contributor.author	Kreutz, Reinhold
dc.contributor.author	Olsen, Michael H.
dc.contributor.author	Lopez-Jaramillo, Patricio
dc.contributor.researchID	10922180 - Schutte, Aletta Elisabeth
dc.date.accessioned	2019-10-08T06:00:28Z
dc.date.available	2019-10-08T06:00:28Z
dc.date.issued	2019
dc.description.abstract	On July 9, 2019, WHO added fixeddose combination antihypertensive medications to the WHO Essential Medicines List. Treatment with fixeddose combination medicines, also known as single-pill combinations, is the emerging best practice for safe, effective, rapid, and convenient hypertension control. But for these essential medicines to improve care and save lives, countries and health systems must ensure that everyone who needs treatment for hypertension can access them	en_US
dc.identifier.citation	Benjamin, I.J. et al. 2019. Fixed-dose combination antihypertensive medications. Lancet, 394(10199):637-638. [https://doi.org/10.1016/S0140-6736(19)31629-0]	en_US
dc.identifier.issn	0140-6736
dc.identifier.issn	1474-547X (Online)
dc.identifier.uri	http://hdl.handle.net/10394/33394
dc.identifier.uri	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31629-0/fulltext
dc.identifier.uri	https://doi.org/10.1016/S0140-6736(19)31629-0
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.title	Fixed-dose combination antihypertensive medications	en_US
dc.type	Article	en_US

Files

Now showing 1 - 1 of 1